Physician profile
Brian C Bai
NPI 1144424102
$1,317.35
in general payments reported to CMS, 2019-2025
12 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $134 · 2021: $192 · 2022: $276 · 2023: $165 · 2024: $69.95 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $501.16 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $153.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $138.88 | 2019-2021 | |
| Edwards Lifesciences Corporation | $134.28 | 2022-2024 | Sapien 3 Ultra Resilia |
| Mannkind Corporation | $124.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $84.80 | 2019 | |
| Exact Sciences Corporation | $62.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $42.19 | 2024-2025 | |
| Lilly USA, LLC | $26.72 | 2021-2023 | Mounjaro |
| Kyowa Kirin, INC. | $22.83 | 2023 | Crysvita |
| Abbott Laboratories | $14.53 | 2023 | Freestyle Libre 2 |
| Vertiflex, INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.